Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 5, Issue 1
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Commentary
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
Online download statistics by month:
Online download statistics by month: December 2019 to May 2022
Abstract
Full
Pdf
Dec 2019
1
1
0
Jan 2020
9
9
2
Feb 2020
19
19
4
Mar 2020
33
33
7
Apr 2020
19
19
1
May 2020
26
26
1
Jun 2020
15
15
1
Jul 2020
14
14
1
Aug 2020
5
5
2
Sep 2020
22
22
2
Oct 2020
24
24
8
Nov 2020
22
21
10
Dec 2020
16
16
3
Jan 2021
14
14
2
Feb 2021
23
23
7
Mar 2021
17
17
4
Apr 2021
29
29
5
May 2021
23
23
6
Jun 2021
15
15
0
Jul 2021
10
10
3
Aug 2021
10
10
4
Sep 2021
19
19
1
Oct 2021
18
18
4
Nov 2021
22
22
6
Dec 2021
21
21
2
Jan 2022
21
23
7
Feb 2022
17
19
5
Mar 2022
18
18
7
Apr 2022
23
25
6
May 2022
36
36
8
Total
561
566
119
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?